ANG Lifesciences India Balance Sheet Health
Financial Health criteria checks 2/6
ANG Lifesciences India has a total shareholder equity of ₹762.8M and total debt of ₹728.4M, which brings its debt-to-equity ratio to 95.5%. Its total assets and total liabilities are ₹2.4B and ₹1.7B respectively.
Key information
95.5%
Debt to equity ratio
₹728.37m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹57.35m |
| Equity | ₹762.77m |
| Total liabilities | ₹1.66b |
| Total assets | ₹2.42b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 540694's short term assets (₹1.8B) exceed its short term liabilities (₹1.4B).
Long Term Liabilities: 540694's short term assets (₹1.8B) exceed its long term liabilities (₹215.9M).
Debt to Equity History and Analysis
Debt Level: 540694's net debt to equity ratio (88%) is considered high.
Reducing Debt: 540694's debt to equity ratio has increased from 61.2% to 95.5% over the past 5 years.
Debt Coverage: 540694's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 540694's interest payments on its debt are well covered by EBIT.